Deutsche Bank: Maintains a "shareholding" rating for tongrentangcm (03613), with a target price lowered to HKD 12.8.
Tong Ren Tang (600085): Large product strategy continues to promote steady growth in parent company performance
Tong Ren Tang (600085): The cost of Chinese herbal medicines affects short-term gross margin and the medium-term dividend rate reached 67.2%
CICC: Maintains a "outperform" rating on tongrentangcm (03613) with a target price of HKD 11.3.
Tong Jin Tang (600085): Mount Manjou has passed
Tong Ren Tang (600085): Overall smooth operation, cost side pressure is expected to be relieved
Tong Ren Tang (600085): Steady increase in main business and increase in dividends
DBS has lowered its target price for tongrentangcm (03613) to HKD 14.8 and maintained its "shareholding" rating.
Tong Ren Tang (600085): 4 Questions 4 Answers: What is the difference in Tong Ren Tang's core expectations?
Research Report Nuggets丨Zheshang Securities: Tong Ren Tang's Q1 performance got off to a good start and should enjoy a higher valuation premium
Tong Ren Tang (600085): A reversal in the performance of leading Chinese medicine brands with state-owned assets brought about valuation repairs
Tong Ren Tang (600085): 1Q24 results are in line with expectations, net profit achieved impressive growth
Tong Ren Tang (600085): Steady profit side growth in 24Q1 and continued to deepen marketing reforms
Tong Ren Tang (600085): Double digit profit growth, good start under high base
Huaan Securities released a research report on April 14 stating that it gave Tong Ren Tang (600085.SH) a purchase rating. The main reasons for the rating include: 1) stable annual performance, with slight pressure on Q4 performance; 2) stable development
Tong Ren Tang (600085): The 23-year performance is in line with expectations, and the number of core products continues to be released
Tong Ren Tang (600085): Continued promotion of large product strategies, rising costs affect gross profit
Tong Ren Tang (600085): Promoting the implementation of a large variety strategy and steady growth in parent company performance
Tong Ren Tang (600085): Performance is expected to maintain steady growth over the next three years
Tong Ren Tang (600085): Performance meets expectations and strengthens retail terminal operation optimization
No Data
No Data